Long-term morbidity following jejunoileal bypass. The continuing potential need for surgical reversal.
OBJECTIVE
To review the late sequelae of jejunoileal bypass (JIB) and the potential role of late surgical reversal in ameliorating morbidity and mortality following JIB.


METHODS
Patients who underwent JIB between 1965 and 1977 were contacted and pertinent health-event information was gathered. Early sequelae were defined as disorders occurring within the first 2 years after JIB; late sequelae were those occurring after 2 years. Health events occurring between 0 and 23 years after JIB were documented.


METHODS
A private, tertiary referral center.


METHODS
Patients underwent JIB for morbid obesity that had failed medical and/or psychiatric interventions.


METHODS
Body mass index (BMI) (weight kilograms divided by the square of the height in meters), diarrhea, electrolyte imbalance, acute, and chronic liver disease, renal disease, JIB reversal, reason for JIB reversal, death, and cause of death.


RESULTS
A total of 453 morbidity obese patients underwent JIB. By 2 years following JIB, the mean (+/- SD) BMI dropped from 49.3 +/- 8.1 to 31.1 +/- 0.8 and remained at this level until year 15, after which weight gradually increased (BMI, 35.4 +/- 3.1). The most severe early complication was acute liver failure, which occurred in 7% of patients and caused seven deaths. At 15 years, the actuarial probability of the most common serious late complications related to JIB were renal disease (37%), with two deaths; diarrhea (29%); and liver disease (10%), with three deaths. One hundred thirty-eight patients (31%) had a bypass reversal. The most common indications for reversal were diarrhea and electrolyte disturbance (29%), renal disease (19%), and liver disease (17%). Fifty-six patients died more than 30 days after JIB: 64% before JIB reversal, 13% at the time of reversal, and 23% subsequently.


CONCLUSIONS
Jejunoileal bypass is associated with progressive accrual of serious, sometimes life-threatening complications. Lifelong follow-up for early diagnosis and surgical reversal before life is threatened should reduce the morbidity and mortality associated with this procedure.
Requarth
J A
JA
Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH.
Burchard
K W
KW
Colacchio
T A
TA
Stukel
T A
TA
Mott
L A
LA
Greenberg
E R
ER
Weismann
R E
RE
D000137:Acid-Base Imbalance / Q000209:etiology; D000206:Actuarial Analysis; D000208:Acute Disease; D000328:Adult; D015992:Body Mass Index; D002423:Cause of Death; D002908:Chronic Disease; D003967:Diarrhea / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007581:Jejunoileal Bypass / Q000009:adverse effects* / Q000401:mortality; D007674:Kidney Diseases / Q000209:etiology; D008107:Liver Diseases / Q000209:etiology; D017114:Liver Failure, Acute / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009513:New Hampshire / Q000453:epidemiology; D009767:Obesity, Morbid / Q000601:surgery; D012086:Reoperation; D015996:Survival Rate; D013997:Time Factors